Lastly, regarding the study of chemoprotectants, recent evidence suggests there may be significant value in investigating protective agents in combination, with data showing that co-treatment of temsirolimus and AMH completely prevented cyclophosphamide-induced primordial follicle loss ( Kashi et al. , 2023 ).
← all excerpts
Anti-Mullerian hormone attenuates both cyclophosphamide-induced damage and PI3K signalling activation, while rapamycin attenuates only PI3K signalling activation, in human ovarian cortex in vitro.
1
—
—